L3 Childhood Acute Lymphoblastic Leukemia
1 clinical trials · Condition
◉ Watch L3 Childhood Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia (NCT00058461) | National Cancer Institute (NCI) | 2003-11-01 |
Track L3 Childhood Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.